Scalise Alessandro, Calamita Roberto, Tartaglione Caterina, Pierangeli Marina, Bolletta Elisa, Gioacchini Matteo, Gesuita Rosaria, Di Benedetto Giovanni
Department of Plastic and Reconstructive Surgery, Università Politecnica delle Marche, Ancona, Italy.
Interdepartmental Centre of Epidemiology, Biostatistics and Medical Informatics (EBI Centre), Università Politecnica delle Marche, Ancona, Italy.
Int Wound J. 2016 Dec;13(6):1260-1281. doi: 10.1111/iwj.12492. Epub 2015 Oct 1.
Advances in preoperative care, surgical techniques and technologies have enabled surgeons to achieve primary closure in a high percentage of surgical procedures. However, often, underlying patient comorbidities in addition to surgical-related factors make the management of surgical wounds primary closure challenging because of the higher risk of developing complications. To date, extensive evidence exists, which demonstrate the benefits of negative pressure dressing in the treatment of open wounds; recently, Incisional Negative Pressure Wound Therapy (INPWT) technology as delivered by Prevena™ (KCI USA, Inc., San Antonio, TX) and Pico (Smith & Nephew Inc, Andover, MA) systems has been the focus of a new investigation on possible prophylactic measures to prevent complications via application immediately after surgery in high-risk, clean, closed surgical incisions. A systematic review was performed to evaluate INPWT's effect on surgical sites healing by primary intention. The primary outcomes of interest are an understanding of INPWT functioning and mechanisms of action, extrapolated from animal and biomedical engineering studies and incidence of complications (infection, dehiscence, seroma, hematoma, skin and fat necrosis, skin and fascial dehiscence or blistering) and other variables influenced by applying INPWT (re-operation and re-hospitalization rates, time to dry wound, cost saving) extrapolated from human studies. A search was conducted for published articles in various databases including PubMed, Google Scholar and Scopus Database from 2006 to March 2014. Supplemental searches were performed using reference lists and conference proceedings. Studies selection was based on predetermined inclusion and exclusion criteria and data extraction regarding study quality, model investigated, epidemiological and clinical characteristics and type of surgery, and the outcomes were applied to all the articles included. 1 biomedical engineering study, 2 animal studies, 15 human studies for a total of 6 randomized controlled trials, 5 prospective cohort studies, 7 retrospective analyses, were included. Human studies investigated the outcomes of 1042 incisions on 1003 patients. The literature shows a decrease in the incidence of infection, sero-haematoma formation and on the re-operation rates when using INPWT. Lower level of evidence was found on dehiscence, decreased in some studies, and was inconsistent to make a conclusion. Because of limited studies, it is difficult to make any assertions on the other variables, suggesting a requirement for further studies for proper recommendations on INPWT.
术前护理、手术技术和科技的进步使外科医生能够在高比例的外科手术中实现一期缝合。然而,除了手术相关因素外,患者潜在的合并症往往使手术伤口一期缝合的管理具有挑战性,因为发生并发症的风险更高。迄今为止,已有大量证据表明负压敷料在治疗开放性伤口方面的益处;最近,由Prevena™(美国KCI公司,得克萨斯州圣安东尼奥)和Pico(美国史赛克公司,马萨诸塞州安多弗)系统提供的切口负压伤口治疗(INPWT)技术,已成为一项新研究的焦点,该研究旨在探讨在高风险、清洁、闭合性手术切口术后立即应用INPWT预防并发症的可能预防措施。进行了一项系统评价,以评估INPWT对手术切口一期愈合的影响。感兴趣的主要结果是从动物和生物医学工程研究中推断出的对INPWT功能和作用机制的了解,以及从人体研究中推断出的并发症(感染、裂开、血清肿、血肿、皮肤和脂肪坏死、皮肤和筋膜裂开或水泡)发生率和其他受应用INPWT影响的变量(再次手术和再次住院率、伤口干燥时间、成本节约)。在包括PubMed、谷歌学术和Scopus数据库在内的多个数据库中,对2006年至2014年3月发表的文章进行了检索。使用参考文献列表和会议论文集进行了补充检索。研究选择基于预先确定的纳入和排除标准,并对研究质量、研究模型、流行病学和临床特征以及手术类型进行数据提取,结果应用于所有纳入的文章。纳入了1项生物医学工程研究、2项动物研究、15项人体研究,共6项随机对照试验、5项前瞻性队列研究、7项回顾性分析。人体研究调查了1003例患者1042个切口的结果。文献表明,使用INPWT时感染、血清血肿形成和再次手术率的发生率降低。关于裂开的证据水平较低,在一些研究中裂开发生率降低,但结果不一致,无法得出结论。由于研究有限,很难对其他变量做出任何断言,这表明需要进一步研究以便对INPWT做出适当的建议。